Objective: To evaluate indications, process, interventions, and effectiveness of patients undergoing intrahospital transport. Critically ill patients supported with extracorporeal membrane oxygenation are transported within the hospital to the radiology suite, cardiac catheterization suite, operating room, and from one intensive care unit to another. No studies to date have systematically evaluated intrahospital transport for patients on extracorporeal membrane oxygenation.
E xtracorporeal membrane oxygenation (ECMO) support, a modified cardiopulmonary bypass technique, has long been an integral part of the management of patients with acute refractory lifethreatening cardiac or respiratory failure. It is initiated when there is an inadequate clinical response to maximal conventional cardiopulmonary support to optimize tissue perfusion and thus preserve organ function (1) .
For patients who receive ECMO support, there are situations when some patients require diagnostic or therapeutic procedures, and therefore, require transport from the intensive care unit to either the cardiac catheterization laboratory or the radiology suite (2) (3) (4) . Although intrahospital transport (IHT) for patients on ECMO may be a crucial part of patient management, it imposes significant risks for the patient . These risks are related to moving critically ill patients on cardiopulmonary support: mechanical ventilation and ECMO support with cannulas placed in major blood vessels and multiple infusions pumps that require multiple long tubings.
The decision to transport a patient receiving ECMO support is based on an assessment of the potential benefits of the transport weighed against the potential risks. Due to the fear of potential for disastrous complications during IHT for patients on ECMO, there may be a reluctance to transport these patients for the required diagnostic and/or therapeutic interventions. Such a delay may hinder optimal patient management and result in suboptimal outcome.
Despite its practice, there is lack of comprehensive published information concerning indications, process, safety, and efficacy of IHT on patients supported with ECMO. We hypothesized that IHT for patients on ECMO support facilitates timely and effective management and can be carried out safely. To investigate this hypothesis, we retrospectively analyzed our institutional experience of IHT for patients on ECMO support over a 10-yr period.
MATERIALS AND METHODS
After obtaining approval from the Institutional Review Board at the University of Arkansas for Medical Sciences, we retrospectively identified from our institutional ECMO database all patients who underwent IHT for computed tomography (CT) scan and/or cardiac catheterization between January 1996 and March 2007. We excluded patients received ECMO support and required IHT to and from the cardiothoracic operating room.
Data were obtained by reviewing the hospital medical records, including ECMO daily care sheets, pharmacy records, cardiac catheterization reports, and daily progress notes written by physicians, nurses, and ECMO coordinators.
During the study period, all patients receiving ECMO support were managed by a dedicated ECMO team and underwent IHT, using standardized management procedure (Appendix 1). IHT of ECMO patients was carried out with specific focus on the preparatory phase, the transfer phase, and the posttransport stabilization. During the preparatory phase, after the decision for IHT was made, the ECMO coordinator would direct the timing and anticipated procedures with the cardiac catheterization suite or the radiology personnel. The bedside nurse, ECMO technician, and the ECMO coordinator completed a checklist to ensure safety during IHT, which included a review of sedation, muscle relaxation, monitors, backup battery, gas supply, blood products, and emergency resuscitation cart. The time for preparation before IHT was approximately 30 mins. The transfer phase consisted of moving the patient on the same bed to the cardiac catheterization and/or the radiology suite table. The ECMO coordinator was responsible during IHT to maintain the optimal position of the ECMO cannulas to minimize inadvertent displacement. The IHT was managed by at least four staff members (ECMO specialist, ECMO coordinator, bedside intensive care unit nurse, nurse practitioners) under the supervision of an attending physician. The patient was hand-bagged during the IHT, which involved moving two or three floors below the ECMO unit. The total transport time for the study included actual transport, transfer from the bed to the CT scan/catheterization table, the time for investigation, and return to the ECMO unit.
The data collected included patient demographics, type and indication for ECMO support, duration of ECMO support before IHT, and details about the IHT (duration; change in management during IHT, such as the need for extra sedation, muscle relaxation, fluid and blood product infusion; and change in ionotropic and ventilatory support). The decision for the IHT was defined in the study as being emergent if it had to be carried out within about 1 hr of clinical indication. Complications related to ECMO circuit, cannulas and endotracheal tube displacement occurring during and within 1 hr of return to the unit were documented.
For patients who underwent cardiac catheterization during IHT, we analyzed the indications for cardiac catheterization and interventions, and correlated echocardiography and cardiac catheterization findings.
Statistical Analysis
Descriptive data are depicted using medians, percentages, and ranges. Fisher's exact test and the unpaired Student's t test were used to calculate p values, where applicable. For the study, p Յ .05 was considered significant.
RESULTS
During the study period, a total of 471 patients received ECMO support with 38 patients requiring 57 IHTs. Thirty-one patients required 37 IHTs for cardiac catheterization, of which 20 were diagnostic and 17 required interventional procedures. Fifteen patients required 20 IHTs to the radiology suite for CT scan of the head. Table 1 shows the characteristics of 37 IHTs to the cardiac catheterization laboratory for diagnostic and interventional purposes. Overall, there were 12 neonates (n ϭ 11 diagnostic; 1 interventional), nine infants (n ϭ 5 diagnostic; 4 interventional), and 12 were Ͼ1 yr old (n ϭ 2 diagnostic; 11 interventional). In the interventional group, transports were undertaken for blade and balloon atrial septostomy (BBAS) (n ϭ 16); endomyocardial biopsies (n ϭ 8), radiofrequency ablation (n ϭ 1), and aortic valvotomy (n ϭ 1).
IHT for Cardiac Catheterization
The median weight for the diagnostic group was 3.8 kg and 12 kg for the interventional group. In the diagnostic group, ten patients were placed on ECMO support for low cardiac output and eight for severe cyanosis. All patients requiring interventions were placed on ECMO for low cardiac output.
The median time from initiation of ECMO to transport for interventional cardiac catheterization was 4 hrs compared with 23 hrs for patients requiring diagnostic catheterization. The median time for the transport and procedure was 119 mins for the diagnostic group compared with 158 mins for the interventional group. In 14 (70%) of 20 patients, there was a management change as a result of the diagnostic cardiac catheterization ( Table 1 ). The details of the specific lesions found in the study cohort are provided in Table 2 . Among the 14 patients, ten patients required surgical interven-tion and were subsequently weaned off ECMO support (Table 2 ).
In the diagnostic cardiac catheterization group, there were 17 patients (n ϭ 18 catheterizations) whose bedside echocardiography findings were compared with cardiac catheterization findings (Table 3). In seven (41%) of 17, the problem was correctly identified by echocardiography, and subsequently confirmed by cardiac catheterization. In the other ten patients (59%), the diagnostic capabilities of bedside echocardiography were limited or problems were not identified. This was particularly a problem in patients who had branch pulmonary arterial and systemic-to-pulmonary artery shunt abnormalities. Table 4 shows the characteristics of 20 IHTs (n ϭ 15 patients) to the radiology suite for CT scan of the head. The indication for these transports was a significant change in neurologic status in patients who received ECMO support, suggestive of the development of a new intracranial event. Of these IHTs for CT scan, 13 (65%) of 20 were carried out on an emergent basis. Significant intracranial pathology was identified in 14 of 15 patients transported on ECMO for head CT scan. The CT abnormalities identified included intracranial hemorrhages (8), massive stroke (3), and severe cerebral edema (7), with uncal herniation (6) and resulted frequently in subsequent withdrawal of the life support (12) .
IHT for CT Scan
The median age and weight for this group of patients was 6 yrs and 15 kg, respectively. The median time from initiation of ECMO to IHT was 40 hrs and the median time for the IHT was 40 mins. The median time of pre-IHT ECMO support in those where the CT scan led to a change in management [81 hrs (range ϭ 1-745 hrs)] was different from those where the CT scan did not lead to a change in management [13 hrs (range ϭ 3-77 hrs)]. Table 5 depicts the details of the changes in ventilatory parameters, acid base balance, requirement for sedation, use of muscle relaxants, and blood products, along with the changes in inotropic support and the complications during the IHT. Most patients received additional sedation and muscle relaxants during the IHT. There were no major mechanical complications, such as cannula dislodgment or circuit rupture. In three patients, however, there was insufficient venous return during IHT which responded to volume bolus. In four patients, there was minor cannula site bleeding requiring no active interventions. ECMO flow changes were made in 14 of 57 IHTs and inotropes were titrated in 12 of 57 IHTs. Additional fluid (5% albumin and blood products) requirement and some changes in acid base status balance were noted in a majority of patients. One patient developed cardiac tamponade during the cardiac catheterization and was appropriately resuscitated.
DISCUSSION
Our study results show that IHT can be carried out safely, facilitating timely diagnosis and effective management of clinically recognized abnormalities. Although IHT is a common practice in experienced ECMO centers, this study provides the first systematic evaluation of its safety and efficacy. Additionally, our results highlight the potential limitations of bedside echocardiography in certain situations and the potential benefit of early cardiac catheterization in these patients.
At our institution, IHT to the cardiac catheterization laboratory for either diagnostic or interventional indications resulted in changing the patient's management in a majority (83.7%) of transported patients. These results are similar to those reported earlier by Booth et al (83%) (2) and desJardins et al (73%) (3) . Lesions demonstrated on cardiac catheterization necessitated surgical or interventional procedures with subsequent successful separation from ECMO support in most cases. Specifically, patients with systemic-to-pulmonary artery shunts or those with pulmonary arterial abnormalities were more likely to have lesions amenable to further interventions, which would result in a change in their management. Our data support the previous experience (2, 3) and assert the need for judicious and early consideration of cardiac catheterization in patients with congenital heart disease requiring ECMO support.
All IHTs to the cardiac catheterization laboratory for interventional indications were for low cardiac output states, and a majority (94.1%) of these were for BBAS for relief of left atrial hypertension and pulmonary edema. One patient required a repeat BBAS due to residual restriction at the atrial level. As shown previously at our institution (5), BBAS is an important part of the optimal management of patients, who have left ventricular failure and who are supported with ECMO; BBAS facilitates adequate reduction of left atrial hypertension and associated pulmonary edema.
Our study is the first to correlate objectively clinical findings on cardiac catheterization with those from echocardiography performed before cardiac catheterization. Our observations suggest that for the interventional group (atrial septostomy and aortic valvotomy) transthoracic echocardiography was adequate in identifying the underlying problem and directing appropriate intervention. In the diagnostic group, however, transthoracic echocardiography was limited in identifying certain abnormalities. In a significant number of patients (59%) with branch pulmonary arterial and shunt abnormalities, the transthoracic echocardiography completed before cardiac catheterization was limited in identifying the pathology. This highlights the limitations of echocardiography, especially in patients with these clinical settings due to poor transthoracic echo windows. Booth and colleagues (2) reported that transthoracic echocardiography in patients supported on ECMO was suboptimal for guiding both diagnosis and therapeutic interventions. However, unlike our study, they have not described details of the correlation between transthoracic echocardiography and subsequent cardiac catheterization nor the types of lesions commonly missed on transthoracic echocardiography. These findings highlight the need for early diagnostic catheterization in selected patients who receive ECMO support. This would provide information for effective management and will minimize the delay in diagnoses, thus improving the overall outcome.
In our study, all IHTs to the radiology suite were for CT scan of the brain to evaluate changes in the patient's neurologic examination. A significant number of CT findings resulted in a change in the patient's management. Our results are similar to the European experience reported by Lidegran et al (4) , although none of our IHT was for thoracic or abdominal CT scan. Our findings reaffirm that a significant change in patients' neurologic status for those who receive ECMO support has a high likelihood of heralding major intracranial pathology, which can be diagnosed promptly by CT scan. Critically ill patients undergoing IHT are at increased risk of morbidity and mortality (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) . For IHT of patients supported with ECMO, the risks are even more considerable. IHT of ECMO patients is a labor-intensive process and requires considerable logistic support and an experienced team. This would be possible with appropriate multidisciplinary team approach with judicious communication and cooperation, particularly with radiology or cardiac catheterization suite staff.
Before every IHT, the team must weigh the potential benefits of the transport against the potential risks. This study demonstrates that IHT for patients who receive ECMO support can be carried out safely and without major complications; however, every patient has the potential for life-threatening complications during IHT. Our experience is similar to that reported by Booth et al (2) and highlights the importance of the being cognizant of the risks for complications during cardiac interventions. The risks of IHT of ECMO-supported patients can be minimized and outcomes can be improved with careful planning, use of trained personnel, and the selection and availability of appropriate equipment.
This study is limited by its retrospective nature and relatively small sample size. Our results may not, therefore, be ECMO, extracorporeal membrane oxygenation; AVSD, atrio-ventricular septal defect; CCF, congestive heart failure; DORV, double outlet right ventricle; HLHS, hypoplastic left heart syndrome; IVC, inferior vena cava; LCOS, low cardiac output syndrome; LVOTO, left ventricular outflow tract obstruction; PA, pulmonary artery; PS, pulmonary stenosis; RMBTS, right modified Blalock Taussig shunt; RVOTO, right ventricular outflow tract obstruction; TAPVR, total anomalous venous return; tGA, transposition of great arteries; ToF, Tetralogy of Fallot; PAT, pulmonary atresia; VSD, ventricular septal defect. applicable universally. The study findings, however, do support clinical practice, in which IHT of ECMO-supported patients has anecdotally been felt to be helpful for optimal management.
CONCLUSIONS
IHT of patients on ECMO, although labor intensive and requiring extensive logistic support, can be carried out safely in experienced hands. Our experience highlights the indications, process, interventions, and effectiveness of IHT of children who receive ECMO support. Further, investigations carried out during IHT to cardiac catheterization laboratory and CT scan often results in important therapeutic and diagnostic information, thereby influencing the management of these patients. Diagnostic ability of transthoracic echocardiography is of limited value in shuntdependent congenital heart lesions and those with branch pulmonary artery abnormalities. The early and judicious use of diagnostic cardiac catheterization is warranted to achieve optimal results.
After clinical decision is made to
perform diagnostic/surgical procedure off the unit, the parents/ family members will be informed and the consent will be obtained. 9. The patient's records (chart, written orders, and labels) will be carried during transport with the patient. 10. The patient's ventilator will accompany the patient during transport to the cardiac catheterization laboratory. 11. The ECMO specialist and the ECMO coordinator will minimize the ECMO pump footprint by removing extra power cords and pumps. The ECMO coordinator will attach a full transport oxygen cylinder and set the flow rate to match the patient's current sweep flow rate. 12. If the patient is being transported to the cardiac catheterization laboratory, the ECMO specialist will check the availability of the activated clotting time machine and cartridge there. 13. Adequate thermal protection should be provided for the patient to maintain normal temperature range.
Transfer Phase
14. The ECMO pump, once unplugged, is automatically on battery power and the ECMO specialist will closely monitor venous return and catheter pressures as well as arteriovenous color difference of the blood. 15. The respiratory therapist will bag and maintain the patient's positive end-expiratory pressure.
16. The ECMO coordinator is responsible for maintaining the optimal position of the ECMO cannulas to minimize inadvertent displacement. 17. At the destination, all power to the ECMO pump and water bath is reeestablished to maintain battery power and to maintain normothermia. 18. The oxygenator should be attached to the main oxygen supply to ensure adequate supply for the return transport. 19. Extra caution will be taken during transfer from the bed on which the patient is transported to the examining/procedural table to minimize accidental adverse events.
Post Transport Stabilization Phase
20. After completion of the diagnostic procedure, the transport process is done in reverse; all staff members will monitor the patient's clinical condition during transport. 21. All the parts of the ECMO circuit are rechecked for new issues. 22. New set of arterial blood gas, electrolyte, complete blood count are checked on return to the unit. 23. Documentation, such as time off unit, time return to unit, procedure done, any interventions performed, any complication and the patient's condition on return to the unit, is performed.
